推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 近年來，我市把建設(shè)“誠信藥都”作為立身之本，落實“四個最嚴(yán)”要求，建立長效機(jī)制，著力打造全國中藥材管理優(yōu)秀、全鏈條質(zhì)量有保障、人民群眾信賴的中藥產(chǎn)業(yè)發(fā)展示范區(qū)。
持續(xù)加強(qiáng)市場監(jiān)管
我市出臺了《關(guān)于建立五大工作機(jī)制推進(jìn)中藥產(chǎn)業(yè)高質(zhì)量發(fā)展的意見》，建立“發(fā)展、追溯、監(jiān)管、誠信、協(xié)同”五大工作機(jī)制。按照“機(jī)制不變、隊伍不散、人員不減、力度不降”的要求，持續(xù)開展藥材藥品綜合整治。今年以來，我市共檢查藥品生產(chǎn)企業(yè)185家，發(fā)現(xiàn)存在缺陷732項，抽檢品種103個、321批次，暫停生產(chǎn)12家，約談23家，告誡22家，責(zé)令整改15家;檢查藥品批發(fā)企業(yè)35家，責(zé)令整改3家;檢查藥品零售連鎖企業(yè)總部5家，責(zé)令整改1家;立案43起，結(jié)案30起;檢查經(jīng)營攤位7809家次、固定門店8187家次，責(zé)令整改11家;檢查零售藥店14111家次，責(zé)令整改205家;檢查醫(yī)療機(jī)構(gòu)6644家次，責(zé)令整改91家;檢查涉藥物流園1060家次，檢查藥材運(yùn)輸車輛826車次，檢查樣品1440組;抽檢藥品藥材583批次。
加快追溯體系建設(shè)
按照“一年抓試點、兩年擴(kuò)面源、三年全覆蓋”的要求，我市有序推進(jìn)中藥生產(chǎn)環(huán)節(jié)信息化追潮體系建設(shè)，先期從中藥飲片為突破口，選擇20個左右涵蓋主要生產(chǎn)范圍的重點中藥飲片品種，遴選15-20家代表性企業(yè)進(jìn)行試用，力爭通過3年的努力，打造涵蓋前端種植、初加工，中端生產(chǎn)、開發(fā)，后端流通、貿(mào)易的中醫(yī)藥全產(chǎn)業(yè)鏈質(zhì)量追溯服務(wù)平臺，進(jìn)一步健全“來源可追溯、去向可查證、責(zé)任可追究”的管控體系。
強(qiáng)化中醫(yī)藥服務(wù)監(jiān)管
我市每季度開展一次全市中醫(yī)醫(yī)療質(zhì)量大檢查，對醫(yī)療質(zhì)量、護(hù)理質(zhì)量、醫(yī)院感染管理、手術(shù)室等進(jìn)行重點排查，進(jìn)行排名，引導(dǎo)“比學(xué)趕超”。加強(qiáng)中醫(yī)醫(yī)療市場監(jiān)管，堅持日常監(jiān)管與突擊執(zhí)法相結(jié)合，開展2期中醫(yī)藥監(jiān)督知識與能力培訓(xùn)、2次中醫(yī)醫(yī)療機(jī)構(gòu)安全生產(chǎn)大檢查，查處欺詐騙保、假借中醫(yī)藥旗號虛假宣傳和售賣虛假產(chǎn)品等違法案件5件，罰款2萬余元。
